logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

NSCLC: osimertinib tops platinum-pemetrexed for CNS lesions

Osimertinib crosses blood-brain border better than first- and second-generation EGFR-TKIs.